Sensory,
Teleoperated,
Intuitive

The first fully-robotic
teleoperated system
for endovascular interventions
Sentante

Endovascular procedures performed remotely with uncompromised feedback force

Sentante enables the remote manipulation of catheters and guidewires
for safe and rapid endovascular disease management

Remote interventions reduce the response time for
stroke, heart attack
and bleeding

Uniqueness
of Sentante:

Disruptive technology:

01

Fully robotic

The manipulation of three endovascular intstruments simultaneously allows the entire procedure to be performed robotically.

02

Teleoperated

The endovascular procedure can be performed from a different room or hospital.

03

Haptic feedback

Physicians can feel the catheter and guidewire just as if they were standing near the patient

04

Universal compatibility

guidewires
A variety of dedicated catheters and guidewires are compatible, with no dependence on the manufacturer

05

Precise manipulation

robotas_1.3.1
Accurate, submillimetric instrument positioning and stent placement

06

Ergonomic workplace

IMG_6707
Allows physicians to fully concentrate on an ongoing case without the use of heavy lead aprons

07

No additional training is needed

robotas_1.3.1

Physicians interface with the robot is via the same endovascular instruments as in a manual procedure

08

Occupational hazards free

robotas_1.11.1
Medical personnel are not exposed to hazardous X-rays
Future
perspectives

01

Training module

Sentante_6-e1622887039610
Realistic training platform with haptic feedback for residents and new physicians

02

Device testing platform

robotas_1.5.1
Simulated models for safe, affordable testing and training of endovascular devices

03

Artificial intelligence based automation

Semi-automated routine tasks such as catheter or guidewire exchange
About Us


Our vision is to transform healthcare by increasing treatment availability for patients and protecting medical personnel from occupational hazard. Our mission is to bring the world’s first fully-robotic system for endovascular interventions to clinical practice for the benefit of patients, physicians, and hospitals.

Our values People focused. We care about patients, medical personnel, and colleagues. Result-based. We are bringing only evidence-based, new medical solutions to the hospitals.

Innovation driven. Constant research and development of the novel medical solutions. Sustainability in mind. Trying not to destroy the planet while supplying the most advanced healthcare solutions.

Management Team

Edvardas Satkauskas

CEO

Experienced entrepreneur, Co-founder of Inovatyvi Medicina

 

 

Dr. Tomas Baltrūnas

CMO

Vascular surgeon, Founder of Inovatyvi Medicina

Perry Van Rijsingen

Board Member

 

Dr. Evaldas Kalvaitis

COO

Co-founder of Inovatyvi Medicina

 

Vilius Dambrauskas

CTO

Co-founder of Inovatyvi Medicina

Vaidas Labunskas

Chief Mechanical Engineer

Co-founder of Inovatyvi Medicina

Ugnė Gurskė

Human Resources Manager

Advisory Board Members

bandymas4[4382]

Dr. Michael Lichtenberg

Medical Advisory Board Member

 
David-Liebeskind[4385]

Dr. David Liebeskind

Medical Advisory Board Member

 
Giovanni-gera[4434]

Dr. Giovanni Torsello

Medical Advisory Board Member

 
Peter-Shneider[4388]

Dr. Peter Schneider

Medical Advisory Board Member

profile-pic (37)

Matt Lemay

Business Advisory Board Member

C.Prentice

Christopher Prentice

Business Advisory Board Member

Route to
market

Expecting launch in 2024

01
Inovatyvi Medicina established
Sentante development began
02
First grant received
Lithuanian Business support agency

01
Hard, dedicated work
TRL4 reached
02
H2020 SME phI grant
Awarded a highly competitive grant
03
Perfect New Year’s party
A solid kickstart into 2019
01
First animal test
Proved to manipulate guidewires perfectly
02
TRL4 reached
Positive feedback from physicians
01
Ongoing animal tests
Again, proved to manipulate guidewires and catheters perfectly
02
TRL5 reached
03
First patent application

EPO

01
TRL6 reached
02
Successful stent implantation
Both Rx and OTW
03

First patent application

01

Work in progress

01

Pre-clinical animal testing

02

Continuing patent applications

News

Leipzig Interventional Course #LINC23!

Incredible opportunity to unveil the first-ever fully robotic endovascular thrombectomy procedure at the Leipzig Interventional Course #LINC23! During presentation, Tomas Baltrunas highlighted the tremendous promise of incorporating robotics

Semmelweis International Vascular Symposium 2023, Budapest

It was an extraordinary opportunity to connect with top experts at the Semmelweis International Vascular Symposium in Budapest, Hungary, where Tomas Baltrunas delivered a captivating presentation, representing Sentante robotic

ML CTO Endovascular Course 2023, Belgium

What an incredible gathering of brilliant minds at #MLCTOENDO2023 Tomas Baltrunas had the privilege of exploring the complex challenges of instent occlusion during a panel discussion at

CX Symposium 2023, London

Just got back from the CX Symposium in London! Tomas Baltrunas gave an incredible presentation on the future of endovascular surgery and remote procedures.The event was a great

Innovation Summit 2023, Dublin

Thrilled to have had the opportunity to share our expertise and learn from other industry leaders at the #innovationdublin23 conference! Edvardas Satkauskas had an honor to talk

#FYA (Find Your Algorithm) 2023, London

Is tactile feedback possible and can we now operate remotely? Tomas Baltrunas had the honor of exploring the question at #FYA (Find Your Algorithm) 2023 conference held in